Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professors Mette M. Rosenkilde and Jens J. Holst have discovered naturally occurring therapeutic peptides that are being investigated in several human studies.
Location: Denmark, Capital Region of Denmark, Copenhagen
Employees: 1-10
Total raised: $87.66M
Founded date: 2017
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.12.2024 | Series A | $84.06M | - |
| 03.06.2020 | - | $3.6M | - |
Mentions in press and media 5
| Date | Title | Description |
| 06.12.2024 | Nebius raises $700M, Sokin acquires fintech Settle, and European tech investment climbed 30% in November | This week we tracked more than 65 tech funding deals worth over €1.3 billion, and over 10 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most i... |
| 04.12.2024 | Antag Therapeutics Raises €80M in Series A Financing | Antag Therapeutics, a Copenhagen, Denmark-based biopharmaceutical company developing new treatments for obesity, raised €80M in Series A funding. The round was led by Versant Ventures, with participation from Novo Holdings, SR One, Dawn Bio... |
| 30.10.2024 | Latest Updates of Viva Biotech's Portfolio Companies | HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies... |
| 28.11.2018 | The Innovators Under 35 Europe 2018 | Technology to eliminate the waste of food, solar strips to regenerate burned skin faster and artificial intelligence that analyzes electrocardiograms as well as a real doctor, among the winning projects The European community will meet on ... |
| - | Antag Therapeutics | “Antag Therapeutics” |